Investigating cerebral vein thrombosis in Norway
Official title: Epidemiology, Clinical and Radiological Presentation and Long-term Prognosis of Cerebral Venous Thrombosis in a Norwegian Population (NoCVT)
Run by University Hospital, Akershus · NCT05021198 · Data updated 2026-11-12
This study looks at how common cerebral vein thrombosis is in Norway, what causes it, how it's treated, and what happens to patients in the long run.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog) |
| Status | Recruiting |
| Started | January 1, 2014 |
| Main results expected | December 31, 2026 |
| Study ends | January 2027 |
| Registry record updated | February 5, 2025 |
| Trial ID | NCT05021198 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with cerebral vein thrombosis between 2014 and 2023 at one of the participating hospitals.
✕Probably not a fit
Patients who do not have a diagnosis of cerebral vein thrombosis or were diagnosed outside the specified timeframe will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Norwegian Cerebral Venous Thrombosis Study aims to explore the epidemiology, risk factors, diagnostics, treatment, and long-term prognosis of cerebral vein thrombosis (CVT) in a large Norwegian population exceeding 3 million. This observational study will utilize a combination of existing health registries and clinical databases, along with new prospectively collected clinical data, to conduct a comprehensive analysis of CVT cases diagnosed between 2014 and 2023. Data will be gathered from 13 hospitals across Norway, allowing for a thorough examination of clinical presentations, treatment outcomes, and long-term health impacts related to CVT.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and outcomes of cerebral vein thrombosis, potentially improving patient care and treatment strategies.
How similar studies have gone: Other studies focusing on cerebral vein thrombosis have shown success in understanding its epidemiology and treatment outcomes, making this approach both relevant and valuable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A diagnosis of CVT 2014-2023 from the 13 participating primary hospitals Exclusion Criteria: * none
Where it's running
-
Akershus University Hospital
Lørenskog, Norway Recruiting
Study contacts
- Principal investigator: Espen Saxhaug Kristoffersen, MD, PhD — University Hospital, Akershus
- Study coordinator: Espen Saxhaug Kristoffersen, MD, PhD
- Email: e.s.kristoffersen@medisin.uio.no
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Danang Cerebral Venous Thrombosis Registry
This registry collects information on adults with cerebral venous thrombosis admitted to Danang Hospital to see how the condition presents, what imaging shows, risk factors, and how patients recover.
-
Erlangen Stroke Registry: A long-running look at stroke in a German community
This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.
-
Endovascular treatment plus anticoagulation for severe CVST in the MENA region
This trial tests whether adding endovascular thrombectomy to standard anticoagulation helps adults with severe cerebral venous sinus thrombosis see better outcomes.
-
Cerebral Venous Thrombosis Cohort: Features and Treatments in China
This study follows people with cerebral venous thrombosis in China to see how the condition presents, progresses, and responds to current treatments, while collecting blood and spinal fluid to explore biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.